mTOR inhibitors derived from rapamycin, namely everolimus and temsirolimus, have been used for the treatment of tuberous sclerosis complex-associated angiomyolipomas (MIM: 191100) and PTEN hamartoma tumor syndrome (PHTS; MIM: 601728) but with mixed results.32 Here, MTOR is linked to PTEN hamartoma tumor syndrome.